tradingkey.logo
搜尋

Cytek Biosciences Inc

CTKB
添加自選
3.405USD
+0.050+1.49%
收盤 05/15, 16:00美東報價延遲15分鐘
437.71M總市值
虧損本益比TTM

Cytek Biosciences Inc

3.405
+0.050+1.49%

關於 Cytek Biosciences Inc 公司

Cytek Biosciences, Inc. is a cell analysis solutions company. The Company is advancing the cell analysis tools by delivering high-resolution, high-content, and high-sensitivity cell analysis utilizing its patented Full Spectrum Profiling (FSP) technology. Its platform includes its core FSP instruments, the Cytek Aurora and Northern Lights systems and the Cytek Aurora CS cell sorter; the Cytek Orion reagent cocktail preparation system; the Enhanced Small Particle (ESP) detection technology; the flow cytometer and imaging products under the Amnis and Guava brands, and reagents, software and service to provide a comprehensive and integrated suite of solutions for its customers. Its Cytek Aurora and Northern Lights systems are used in the study of infectious diseases, immunology, immunotherapy, immuno-oncology, oncology, and drug discovery. The Cytek Orion reagent cocktail preparation system enables researchers to fully automate the preparation of antibody cocktails for flow cytometry.

Cytek Biosciences Inc簡介

公司代碼CTKB
公司名稱Cytek Biosciences Inc
上市日期Jul 23, 2021
CEOJiang (Wenbin)
員工數量648
證券類型Ordinary Share
年結日Jul 23
公司地址47215 Lakeview Boulevard
城市FREMONT
上市交易所NASDAQ OMX - NASDAQ BASIC
國家United States of America
郵編94538
電話18779229835
網址https://cytekbio.com
公司代碼CTKB
上市日期Jul 23, 2021
CEOJiang (Wenbin)

Cytek Biosciences Inc公司高管

名稱
名稱/職務
職務
持股
持股變動
Dr. Wenbin Jiang, Ph.D.
Dr. Wenbin Jiang, Ph.D.
Chairman of the Board, President, Chief Executive Officer, Co-Founder
Chairman of the Board, President, Chief Executive Officer, Co-Founder
5.42M
+1.16%
Dr. Ming Yan, Ph.D.
Dr. Ming Yan, Ph.D.
Co-Founder, Chief Technology Officer, Director
Co-Founder, Chief Technology Officer, Director
4.92M
-23.56%
Ms. Valerie Barnett, J.D.
Ms. Valerie Barnett, J.D.
Chief Legal Officer and Corporate Secretary
Chief Legal Officer and Corporate Secretary
134.44K
+13.37%
Dr. Vera Imper, Ph.D.
Dr. Vera Imper, Ph.D.
Independent Director
Independent Director
15.71K
--
Ms. Deborah J. Neff
Ms. Deborah J. Neff
Lead Independent Director
Lead Independent Director
15.71K
--
Mr. Michael Holder
Mr. Michael Holder
Independent Director
Independent Director
15.27K
+19.05%
Mr. Jack T. Ball, Jr.
Mr. Jack T. Ball, Jr.
Independent Director
Independent Director
--
--
Mr. William (Bill) Mccombe
Mr. William (Bill) Mccombe
Chief Financial Officer
Chief Financial Officer
--
--
Dr. Philippe Busque, Ph.D.
Dr. Philippe Busque, Ph.D.
Senior Vice President, Global Sales and Services
Senior Vice President, Global Sales and Services
--
--
名稱
名稱/職務
職務
持股
持股變動
Dr. Wenbin Jiang, Ph.D.
Dr. Wenbin Jiang, Ph.D.
Chairman of the Board, President, Chief Executive Officer, Co-Founder
Chairman of the Board, President, Chief Executive Officer, Co-Founder
5.42M
+1.16%
Dr. Ming Yan, Ph.D.
Dr. Ming Yan, Ph.D.
Co-Founder, Chief Technology Officer, Director
Co-Founder, Chief Technology Officer, Director
4.92M
-23.56%
Ms. Valerie Barnett, J.D.
Ms. Valerie Barnett, J.D.
Chief Legal Officer and Corporate Secretary
Chief Legal Officer and Corporate Secretary
134.44K
+13.37%
Dr. Vera Imper, Ph.D.
Dr. Vera Imper, Ph.D.
Independent Director
Independent Director
15.71K
--
Ms. Deborah J. Neff
Ms. Deborah J. Neff
Lead Independent Director
Lead Independent Director
15.71K
--
Mr. Michael Holder
Mr. Michael Holder
Independent Director
Independent Director
15.27K
+19.05%

收入明細

單位: USD更新時間: 4月6日 週一
單位: USD更新時間: 4月6日 週一
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
業務USD
名稱
營收
佔比
Biotechnology, pharmaceutical, distributor and CRO
116.73M
57.93%
Academia and government
84.76M
42.07%
地區USD
名稱
營收
佔比
United States
95.25M
47.27%
EMEA
55.88M
27.73%
APAC
41.08M
20.39%
Other
9.28M
4.61%
業務
地區
業務USD
名稱
營收
佔比
Biotechnology, pharmaceutical, distributor and CRO
116.73M
57.93%
Academia and government
84.76M
42.07%

股東統計

更新時間: 5月10日 週日
更新時間: 5月10日 週日
持股股東
股東類型
持股股東
持股股東
佔比
BlackRock Institutional Trust Company, N.A.
12.28%
Topline Capital Management, LLC
5.76%
HHLR Advisors, Ltd.
5.15%
Millennium Management LLC
5.14%
Boston Partners
4.49%
其他
67.17%
持股股東
持股股東
佔比
BlackRock Institutional Trust Company, N.A.
12.28%
Topline Capital Management, LLC
5.76%
HHLR Advisors, Ltd.
5.15%
Millennium Management LLC
5.14%
Boston Partners
4.49%
其他
67.17%
股東類型
持股股東
佔比
Investment Advisor
28.48%
Investment Advisor/Hedge Fund
23.66%
Hedge Fund
12.30%
Individual Investor
8.35%
Research Firm
1.42%
Pension Fund
0.76%
Bank and Trust
0.21%
Family Office
0.10%
Insurance Company
0.03%
其他
24.70%

機構持股

更新時間: 4月1日 週三
更新時間: 4月1日 週三
報告期間
機構數
持股數
持股佔比
持股變動
2026Q1
335
84.13M
65.16%
-7.06M
2025Q4
319
80.93M
70.83%
-2.20K
2025Q3
325
80.93M
70.98%
+589.69K
2025Q2
322
80.49M
71.67%
+1.88M
2025Q1
319
78.68M
72.45%
-13.77M
2024Q4
315
78.50M
69.87%
+2.46M
2024Q3
291
75.89M
70.06%
-1.14M
2024Q2
277
76.97M
68.86%
-4.44M
2024Q1
273
87.08M
76.11%
-12.82M
2023Q4
268
85.37M
77.21%
+1.48M
查看更多

股東持股明細

名稱
持股數
佔比
持股變動
變動比例
公告日期
BlackRock Institutional Trust Company, N.A.
15.86M
12.33%
+652.15K
+4.29%
Dec 31, 2025
Topline Capital Management, LLC
7.44M
5.79%
+498.19K
+7.17%
Dec 31, 2025
HHLR Advisors, Ltd.
6.66M
5.18%
--
--
Dec 31, 2025
Millennium Management LLC
4.75M
3.7%
+1.33M
+39.03%
Dec 31, 2025
Boston Partners
5.01M
3.9%
+4.97M
+13369.35%
Dec 31, 2025
Jiang (Wenbin)
5.42M
4.22%
+62.86K
+1.17%
Mar 10, 2026
Yan (Ming)
4.92M
3.82%
-1.16M
-19.07%
Mar 13, 2026
State Street Investment Management (US)
4.15M
3.23%
+62.60K
+1.53%
Dec 31, 2025
Geode Capital Management, L.L.C.
2.79M
2.17%
+7.13K
+0.26%
Dec 31, 2025
查看更多

持股ETF

更新時間: 12月6日 週六
更新時間: 12月6日 週六
機構名稱
佔比
Invesco S&P SmallCap Health Care ETF
0.26%
Royce Quant Small-Cap Quality Value ETF
0.22%
iShares S&P Small-Cap 600 Value ETF
0.09%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0.07%
State Street SPDR S&P 600 Small Cap Value ETF
0.06%
Avantis US Small Cap Equity ETF
0.05%
Invesco S&P SmallCap 600 QVM Multi-factor ETF
0.05%
Fidelity Enhanced Small Cap ETF
0.05%
Principal U.S. Small-Cap ETF
0.05%
WisdomTree US SmallCap Fund
0.04%
查看更多
Invesco S&P SmallCap Health Care ETF
佔比0.26%
Royce Quant Small-Cap Quality Value ETF
佔比0.22%
iShares S&P Small-Cap 600 Value ETF
佔比0.09%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
佔比0.07%
State Street SPDR S&P 600 Small Cap Value ETF
佔比0.06%
Avantis US Small Cap Equity ETF
佔比0.05%
Invesco S&P SmallCap 600 QVM Multi-factor ETF
佔比0.05%
Fidelity Enhanced Small Cap ETF
佔比0.05%
Principal U.S. Small-Cap ETF
佔比0.05%
WisdomTree US SmallCap Fund
佔比0.04%

分紅派息

近5年累計派現 0.00 美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據

拆合股

公告日期
除權除息日
類型
比率
暫無數據
公告日期
除權除息日
類型
比率
暫無數據
KeyAI